{
  "api_version": "1",
  "request": {
    "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blood+glucose+CV",
    "query": {
      "intervention": "Blood glucose CV"
    },
    "page_size": 10
  },
  "pagination": {
    "page": 1,
    "page_size": 10,
    "total_count": 4,
    "total_pages": 1,
    "next_page_url": null,
    "previous_page_url": null
  },
  "source": "remote",
  "last_synced_at": "2026-09-13T18:21:35.552Z",
  "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.",
  "notes": [
    "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.",
    "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.",
    "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees."
  ],
  "trials": [
    {
      "nct_id": "NCT04675593",
      "title": "Using mHealth to Improve Adherence and Reduce Blood Pressure in Individuals With Hypertension and Mood Disorders",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Bipolar Disorder",
        "Non-Adherence, Medication",
        "Hypertension",
        "Major Depressive Disorder"
      ],
      "interventions": [
        {
          "name": "iTAB-CV",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Self-Monitoring",
          "type": "BEHAVIORAL"
        }
      ],
      "intervention_types": [
        "BEHAVIORAL"
      ],
      "sponsor": "Case Western Reserve University",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "21 Years",
        "maximum_age": "80 Years",
        "sex": "ALL",
        "summary": "21 Years to 80 Years"
      },
      "enrollment_count": 176,
      "start_date": "2021-03-15",
      "completion_date": "2026-05-29",
      "has_results": false,
      "last_update_posted_date": "2026-06-11",
      "last_synced_at": "2026-09-13T18:21:35.552Z",
      "location_count": 1,
      "location_summary": "Cleveland, Ohio",
      "locations": [
        {
          "city": "Cleveland",
          "state": "Ohio"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT04675593"
    },
    {
      "nct_id": "NCT05166382",
      "title": "Impact of SomaSignal Tests on the Choice of Glucose-lowering Medications",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Type 2 Diabetes",
        "Cardiovascular Diseases"
      ],
      "interventions": [
        {
          "name": "Informed of results from SomaSignal Cardiovascular Risk Test in Type 2 Diabetes (CVD-T2D)",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Not informed of results from SomaSignal Cardiovascular Risk Test in Type 2 Diabetes (CVD-T2D)",
          "type": "BEHAVIORAL"
        }
      ],
      "intervention_types": [
        "BEHAVIORAL"
      ],
      "sponsor": "University of Colorado, Denver",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "40 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "40 Years and older"
      },
      "enrollment_count": 350,
      "start_date": "2022-01-01",
      "completion_date": "2024-01-01",
      "has_results": false,
      "last_update_posted_date": "2025-03-20",
      "last_synced_at": "2026-09-13T18:21:35.552Z",
      "location_count": 1,
      "location_summary": "Aurora, Colorado",
      "locations": [
        {
          "city": "Aurora",
          "state": "Colorado"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT05166382"
    },
    {
      "nct_id": "NCT03334318",
      "title": "PERL Continuous Glucose Monitoring (CGM) Study",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Diabetic Nephropathies"
      ],
      "interventions": [
        {
          "name": "Mean blood glucose",
          "type": "OTHER"
        },
        {
          "name": "Blood glucose CV",
          "type": "OTHER"
        },
        {
          "name": "% time 70-180 mg/dL",
          "type": "OTHER"
        },
        {
          "name": "% time below 54 mg/dL",
          "type": "OTHER"
        },
        {
          "name": "% time above 180 mg/dL",
          "type": "OTHER"
        },
        {
          "name": "% time above 250 mg/dL",
          "type": "OTHER"
        },
        {
          "name": "MAGE (Mean amplitude of glucose excursions)",
          "type": "OTHER"
        },
        {
          "name": "LBGI (Low Blood Glucose Index)",
          "type": "OTHER"
        },
        {
          "name": "HBGI (High Blood Glucose Index)",
          "type": "OTHER"
        },
        {
          "name": "Allopurinol",
          "type": "DRUG"
        },
        {
          "name": "Placebo",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "OTHER",
        "DRUG"
      ],
      "sponsor": "Joslin Diabetes Center",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "70 Years",
        "sex": "ALL",
        "summary": "18 Years to 70 Years"
      },
      "enrollment_count": 175,
      "start_date": "2017-10-01",
      "completion_date": "2021-12-31",
      "has_results": false,
      "last_update_posted_date": "2022-03-29",
      "last_synced_at": "2026-09-13T18:21:35.552Z",
      "location_count": 15,
      "location_summary": "Aurora, Colorado • Atlanta, Georgia • Chicago, Illinois + 11 more",
      "locations": [
        {
          "city": "Aurora",
          "state": "Colorado"
        },
        {
          "city": "Atlanta",
          "state": "Georgia"
        },
        {
          "city": "Chicago",
          "state": "Illinois"
        },
        {
          "city": "Boston",
          "state": "Massachusetts"
        },
        {
          "city": "Ann Arbor",
          "state": "Michigan"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT03334318"
    },
    {
      "nct_id": "NCT04735874",
      "title": "Vascular Health and Risk Factors in Children With Down Syndrome",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Down Syndrome",
        "Cardiovascular Risk Factor",
        "Atherosclerosis"
      ],
      "interventions": [
        {
          "name": "Evaluate vascular disease risk factors in children with Down Syndrome",
          "type": "OTHER"
        },
        {
          "name": "Determine the associations between cardiovascular disease risk factors and markers of early atherosclerosis in children with Down Syndrome",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "OTHER"
      ],
      "sponsor": "University of Utah",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "10 Years",
        "maximum_age": "18 Years",
        "sex": "ALL",
        "summary": "10 Years to 18 Years"
      },
      "enrollment_count": 55,
      "start_date": "2021-02-02",
      "completion_date": "2023-06-30",
      "has_results": false,
      "last_update_posted_date": "2023-08-14",
      "last_synced_at": "2026-09-13T18:21:35.552Z",
      "location_count": 1,
      "location_summary": "Salt Lake City, Utah",
      "locations": [
        {
          "city": "Salt Lake City",
          "state": "Utah"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT04735874"
    }
  ]
}